Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Vecabrutinib - Sunesis Pharmaceuticals

Drug Profile

Vecabrutinib - Sunesis Pharmaceuticals

Alternative Names: SNS 062; SNS-062-succinate

Latest Information Update: 06 Jan 2019

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Biogen Idec; Sunesis Pharmaceuticals
  • Developer Biogen; Sunesis Pharmaceuticals
  • Class Amides; Antineoplastics; Piperidines; Pyrimidines; Small molecules; Succinates
  • Mechanism of Action Agammaglobulinaemia tyrosine kinase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase I/II Haematological malignancies

Most Recent Events

  • 02 Dec 2018 Preliminary pharmacodynamics, pharmacokinetics and adverse data from a phaseIb/II trial in Haematological malignancies presented at the 60th Annual Meeting and Exposition of the American Society of Hematology (ASH-Hem 2018)
  • 01 Dec 2018 Pharmacodynamics and immunogenicity data from a preclinical trial in Haematological malignancies presented at the 60th Annual Meeting and Exposition of the American Society of Hematology (ASH-Hem-2018)
  • 22 Nov 2018 Chemical structure information added
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top